Stelara and Pregnancy/Breastfeeding: What You Need to Know

Understanding Stelara's Use During Pregnancy and Breastfeeding

For individuals managing chronic conditions like psoriasis, psoriatic arthritis, Crohn's disease, or ulcerative colitis, Stelara (ustekinumab) can be a highly effective treatment. However, when pregnancy or breastfeeding comes into the picture, many questions arise about the safety and potential effects of continuing such medications. This guide aims to provide clear, practical information for Indian readers regarding the use of Stelara during pregnancy and lactation, drawing from available medical knowledge and expert recommendations.

Stelara and Pregnancy: What the Science Says

The decision to use any medication during pregnancy requires careful consideration of both potential benefits and risks. When it comes to Stelara, the scientific understanding is still evolving. Here's what we know:

• Limited Human Studies: It is not definitively known whether Stelara can harm an unborn baby. This is primarily because human studies specifically designed to prove safety or risks during pregnancy are not large enough. Medical professionals rely on a combination of clinical trial data, other studies, and reports from individuals who have taken Stelara while pregnant.
• Prescribing Information: Due to the limited data, Stelara's official prescribing information does not explicitly state whether the drug causes problems for unborn babies. While it doesn't list specific risks, it also doesn't rule them out. The information indicates that there isn't enough evidence to link Stelara with specific adverse pregnancy outcomes.
• Placental Transfer: Proteins similar to Stelara can cross the placenta, particularly in the later stages of pregnancy. This means that if Stelara is taken during pregnancy, there is a possibility that the medication could reach the developing baby.

Pregnancy Registries: Contributing to Knowledge

For those using Stelara and planning a pregnancy or who discover they are pregnant while on treatment, enrolling in a pregnancy registry is highly recommended. These registries are crucial for gathering more comprehensive data on the effects of medications during pregnancy. By participating, you contribute valuable information that can help future patients and healthcare providers make more informed decisions.

How to Enroll: You can enroll in the Stelara pregnancy registry by calling 866-626-6847 or visiting the designated website. Your participation is voluntary and confidential.

Stelara and Breastfeeding: Understanding the Risks

Similar to pregnancy, the use of Stelara during breastfeeding warrants careful consideration. The presence of the drug in breast milk and its potential effects on a nursing infant are key concerns.

• Presence in Breast Milk: Stelara can pass into breast milk. Limited published data suggest that small amounts of ustekinumab (the active ingredient in Stelara) may be present in human milk.
• Unknown Effects on Infants: Experts are still uncertain about how these small amounts might affect a breastfed infant. The long-term implications are not yet fully understood.
• Benefits of Breastfeeding: It's important to remember the significant developmental and health benefits that breastfeeding provides for children. This needs to be weighed against the potential risks associated with medication exposure.

Key Questions to Discuss with Your Doctor

Making informed decisions about continuing Stelara during pregnancy or breastfeeding requires open communication with your healthcare team. Here are some important questions to consider and discuss:

1. What is currently known and unknown about Stelara's effects on unborn babies and infants during breastfeeding?
2. Should I consider enrolling in the pregnancy registry to help gather more data?
3. How might the amount of Stelara crossing the placenta affect the baby, and can this be monitored during pregnancy?
4. Am I clear on the benefits of breastfeeding and the reasons why I am taking Stelara for my condition?
5. Are there alternative treatments for my condition that have more established safety data regarding pregnancy and lactation?

When to Consult Your Doctor

It is essential to consult your doctor before you stop, start, or change any medication, especially if you are pregnant, planning to become pregnant, or breastfeeding.

• Discuss Your Condition: Talk about how your condition is managed and the importance of treatment for your health and well-being.
• Explore Alternatives: Discuss potential alternative treatments that might have more data available regarding safety in pregnancy and lactation.
• Weigh Risks and Benefits: Work with your doctor to weigh the known benefits of Stelara for your health against the potential, though not definitively proven, risks to your baby.
• Personalized Advice: Your doctor can provide personalized advice based on your medical history, the severity of your condition, and the latest medical evidence.

Conclusion

Managing chronic conditions while navigating pregnancy and breastfeeding presents unique challenges. While the data on Stelara's use in these situations is limited, ongoing research and participation in pregnancy registries are helping to build a clearer picture. The most crucial step is to maintain an open dialogue with your healthcare provider. Together, you can make the best-informed decision for both your health and the well-being of your child.